Shareholder alert: robbins llp announces that aquestive therapeutics, inc. (aqst) is being sued for misleading shareholders

San diego & warren, n.j.--(business wire)---- $aqst #classaction--shareholder rights law firm robbins llp announces that a purchaser of aquestive therapeutics, inc. (nasdaq: aqst) filed a class action complaint against the company and its officers and directors for alleged violations of the securities exchange act of 1934 between december 2, 2019 and september 25, 2020. aquestive is a specialty pharmaceutical company that develops products to address unmet medical needs. the company's most advanced proprietary produc
AQST Ratings Summary
AQST Quant Ranking